Literature DB >> 10866799

A trans-acting factor, isolated by the three-hybrid system, that influences alternative splicing of the amyloid precursor protein minigene.

A Poleev1, A Hartmann, S Stamm.   

Abstract

Two clones were isolated in a three-hybrid screen of a rat fetal brain P5 cDNA library with an intronic splicing enhancer of the amyloid precursor protein (APP) gene as RNA bait. These clones represent the rat homologues of the previously described genes CUG-binding protein (CUG-BP) and Siah-binding protein (Siah-BP). Both interact in a sequence-specific manner with the RNA bait used for library screening as well as with the CUG repeat. In contrast, no interactions were observed in the three-hybrid assay with other baits tested. In two-hybrid assays, Siah-BP interacts with U2AF65 as well as with itself. EWS, an RGG-type RNA-binding protein associated with Ewing sarcoma, was identified as an interacting partner for the CUG-BP homologue in a two-hybrid assay for protein-protein interactions performed with various factors involved in RNA metabolism. Splicing assays performed by RT-PCR from cells cotransfected with certain cDNAs and an APP minigene, used as a reporter, indicate exclusion of exon 8 if the CUG-BP homologue is present. We conclude that clone AF169013 and its counterpart in human CUG-BP could be the trans-acting factors that interact with the splicing enhancer downstream of exon 8, and in this way influence alternative splicing of the APP minigene.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10866799     DOI: 10.1046/j.1432-1327.2000.01431.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  13 in total

Review 1.  U2AF homology motifs: protein recognition in the RRM world.

Authors:  Clara L Kielkopf; Stephan Lücke; Michael R Green
Journal:  Genes Dev       Date:  2004-07-01       Impact factor: 11.361

2.  Thioredoxin as a fusion tag for carrier-driven crystallization.

Authors:  Lorenzo Corsini; Michael Hothorn; Klaus Scheffzek; Michael Sattler; Gunter Stier
Journal:  Protein Sci       Date:  2008-09-09       Impact factor: 6.725

3.  An analysis of the sequence requirements of EDEN-BP for specific RNA binding.

Authors:  Sylvie Bonnet-Corven; Yann Audic; Francis Omilli; H Beverley Osborne
Journal:  Nucleic Acids Res       Date:  2002-11-01       Impact factor: 16.971

4.  CUG-BP1/CELF1 requires UGU-rich sequences for high-affinity binding.

Authors:  Julien Marquis; Luc Paillard; Yann Audic; Bertrand Cosson; Olivier Danos; Christine Le Bec; H Beverley Osborne
Journal:  Biochem J       Date:  2006-12-01       Impact factor: 3.857

Review 5.  The importance of CELF control: molecular and biological roles of the CUG-BP, Elav-like family of RNA-binding proteins.

Authors:  Twishasri Dasgupta; Andrea N Ladd
Journal:  Wiley Interdiscip Rev RNA       Date:  2011-08-17       Impact factor: 9.957

Review 6.  CUG-BP, Elav-like family (CELF)-mediated alternative splicing regulation in the brain during health and disease.

Authors:  Andrea N Ladd
Journal:  Mol Cell Neurosci       Date:  2012-12-14       Impact factor: 4.314

7.  A role for SC35 and hnRNPA1 in the determination of amyloid precursor protein isoforms.

Authors:  R Donev; A Newall; J Thome; D Sheer
Journal:  Mol Psychiatry       Date:  2007-03-13       Impact factor: 15.992

8.  Alternative splicing produces structural and functional changes in CUGBP2.

Authors:  Hitoshi Suzuki; Makoto Takeuchi; Ayumu Sugiyama; Ahm Khurshid Alam; Luyen Thi Vu; Yoshiharu Sekiyama; Hieu Chi Dam; Shin-Ya Ohki; Toshifumi Tsukahara
Journal:  BMC Biochem       Date:  2012-03-20       Impact factor: 4.059

9.  Control of pre-mRNA splicing by the general splicing factors PUF60 and U2AF(65).

Authors:  Michelle L Hastings; Eric Allemand; Dominik M Duelli; Michael P Myers; Adrian R Krainer
Journal:  PLoS One       Date:  2007-06-20       Impact factor: 3.240

10.  Dimerization of FIR upon FUSE DNA binding suggests a mechanism of c-myc inhibition.

Authors:  Gregg V Crichlow; Hongwen Zhou; Hsin-hao Hsiao; Kendra B Frederick; Maxime Debrosse; Yuande Yang; Ewa J Folta-Stogniew; Hye-Jung Chung; Chengpeng Fan; Enrique M De la Cruz; David Levens; Elias Lolis; Demetrios Braddock
Journal:  EMBO J       Date:  2007-12-06       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.